These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21212552)

  • 1. Development of bioluminescent enzyme immunoassay for s-equol using firefly luciferase and its application to the assessment of equol-producer status.
    Minekawa T; Kambegawa A; Shindome K; Ohkuma H; Abe K; Maekawa H; Arakawa H
    Chem Pharm Bull (Tokyo); 2011; 59(1):84-7. PubMed ID: 21212552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Method of defining equol-producer status and its frequency among vegetarians.
    Setchell KD; Cole SJ
    J Nutr; 2006 Aug; 136(8):2188-93. PubMed ID: 16857839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal cut-off value for equol-producing status in women: The Japan Nurses' Health Study urinary isoflavone concentration survey.
    Ideno Y; Hayashi K; Nakajima-Shimada J; Onizuka Y; Kishi M; Ueno T; Uchiyama S
    PLoS One; 2018; 13(7):e0201318. PubMed ID: 30048499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of urinary daidzein and equol by gas chromatography after solid-phase extraction and high-performance liquid chromatography.
    Venturelli E; Rinaldi S; Cambiè M; Cavalleri A; Secreto G
    Int J Biol Markers; 2002; 17(3):182-8. PubMed ID: 12408469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of equol producers in a Japanese population by high-performance liquid chromatography with coulometric array for determining serum isoflavones.
    Zhao JH; Sun SJ; Arao Y; Oguma E; Yamada K; Horiguchi H; Kayama F
    Phytomedicine; 2006 May; 13(5):304-9. PubMed ID: 16635737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Being overweight or obese is associated with harboring a gut microbial community not capable of metabolizing the soy isoflavone daidzein to O-desmethylangolensin in peri- and post-menopausal women.
    Miller LM; Lampe JW; Newton KM; Gundersen G; Fuller S; Reed SD; Frankenfeld CL
    Maturitas; 2017 May; 99():37-42. PubMed ID: 28364866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical application of bioluminescence enzyme immunoassay using enhancer for firefly luciferin-luciferase bioluminescence.
    Minekawa T; Ohkuma H; Abe K; Maekawa H; Arakawa H
    Luminescence; 2011; 26(3):167-71. PubMed ID: 21681909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of equol by postmenopausal women consuming soymilk fermented by probiotic bifidobacteria.
    Tsangalis D; Wilcox G; Shah NP; McGill AE; Stojanovska L
    Eur J Clin Nutr; 2007 Mar; 61(3):438-41. PubMed ID: 17021598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel UHPLC method for the rapid and simultaneous determination of daidzein, genistein and equol in human urine.
    Redruello B; Guadamuro L; Cuesta I; Álvarez-Buylla JR; Mayo B; Delgado S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Nov; 1005():1-8. PubMed ID: 26444491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High concordance of daidzein-metabolizing phenotypes in individuals measured 1 to 3 years apart.
    Frankenfeld CL; Atkinson C; Thomas WK; Gonzalez A; Jokela T; Wähälä K; Schwartz SM; Li SS; Lampe JW
    Br J Nutr; 2005 Dec; 94(6):873-6. PubMed ID: 16351761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daidzein reductase of Eggerthella sp. YY7918, its octameric subunit structure containing FMN/FAD/4Fe-4S, and its enantioselective production of R-dihydroisoflavones.
    Kawada Y; Goshima T; Sawamura R; Yokoyama SI; Yanase E; Niwa T; Ebihara A; Inagaki M; Yamaguchi K; Kuwata K; Kato Y; Sakurada O; Suzuki T
    J Biosci Bioeng; 2018 Sep; 126(3):301-309. PubMed ID: 29699942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inter- and intra-individual variation in urinary excretion of daidzein and equol in female Japanese.
    Suzuki Y; Hisada A; Yoshinaga J
    Biomarkers; 2014 Aug; 19(5):407-10. PubMed ID: 24842557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women.
    Zubik L; Meydani M
    Am J Clin Nutr; 2003 Jun; 77(6):1459-65. PubMed ID: 12791624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cross-sectional study of equol producer status and self-reported vasomotor symptoms.
    Newton KM; Reed SD; Uchiyama S; Qu C; Ueno T; Iwashita S; Gunderson G; Fuller S; Lampe JW
    Menopause; 2015 May; 22(5):489-95. PubMed ID: 25380274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daidzein Intake Is Associated with Equol Producing Status through an Increase in the Intestinal Bacteria Responsible for Equol Production.
    Iino C; Shimoyama T; Iino K; Yokoyama Y; Chinda D; Sakuraba H; Fukuda S; Nakaji S
    Nutrients; 2019 Feb; 11(2):. PubMed ID: 30791484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammographic density in relation to daidzein-metabolizing phenotypes in overweight, postmenopausal women.
    Frankenfeld CL; McTiernan A; Aiello EJ; Thomas WK; LaCroix K; Schramm J; Schwartz SM; Holt VL; Lampe JW
    Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1156-62. PubMed ID: 15247126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-month exposure to soy isoflavones did not induce the ability to produce equol in postmenopausal women.
    Védrine N; Mathey J; Morand C; Brandolini M; Davicco MJ; Guy L; Rémésy C; Coxam V; Manach C
    Eur J Clin Nutr; 2006 Sep; 60(9):1039-45. PubMed ID: 16482068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability and urinary excretion of isoflavones in humans: effects of soy-based supplements formulation and equol production.
    Vergne S; Titier K; Bernard V; Asselineau J; Durand M; Lamothe V; Potier M; Perez P; Demotes-Mainard J; Chantre P; Moore N; Bennetau-Pelissero C; Sauvant P
    J Pharm Biomed Anal; 2007 Mar; 43(4):1488-94. PubMed ID: 17110073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of ultra-high sensitivity bioluminescent enzyme immunoassay for hepatitis B virus surface antigen using firefly luciferase.
    Minekawa T; Ohkuma H; Abe K; Maekawa H; Arakawa H
    Luminescence; 2009; 24(6):394-9. PubMed ID: 19424965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural elucidation of hydroxylated metabolites of the isoflavan equol by gas chromatography-mass spectrometry and high-performance liquid chromatography-mass spectrometry.
    Rüfer CE; Glatt H; Kulling SE
    Drug Metab Dispos; 2006 Jan; 34(1):51-60. PubMed ID: 16199471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.